BRPI0519270A2 - composiÇço farmacÊutica particulada estÁvel de solifenacina ou um sal - Google Patents

composiÇço farmacÊutica particulada estÁvel de solifenacina ou um sal

Info

Publication number: BRPI0519270A2
Authority: BR; Brazil
Prior art keywords: salt; pharmaceutical composition; solifenacin; granular; stable
Prior art date: 2004-12-27

Application number

BRPI0519270-6A

Other languages

English (en)

Portuguese (pt)

Inventor

Hiroyuki Umejima

Hiroshi Ohi

Katsumi Saito

Yuko Taketani

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-27

Filing date

2005-12-26

Publication date

2009-01-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40283425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0519270(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-26 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2005-12-26 Priority claimed from PCT/JP2005/023771 external-priority patent/WO2006070735A1/ja

2009-01-06 Publication of BRPI0519270A2 publication Critical patent/BRPI0519270A2/pt

Links

FBOUYBDGKBSUES-VXKWHMMOSA-N solifenacin Chemical compound C1([C@H]2C3=CC=CC=C3CCN2C(O[C@@H]2C3CCN(CC3)C2)=O)=CC=CC=C1 FBOUYBDGKBSUES-VXKWHMMOSA-N 0.000 title abstract 6
229960003855 solifenacin Drugs 0.000 title abstract 6
239000008194 pharmaceutical composition Substances 0.000 title abstract 5
150000003839 salts Chemical class 0.000 title abstract 5
239000000203 mixture Substances 0.000 abstract 2
230000032683 aging Effects 0.000 abstract 1
239000011230 binding agent Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
238000002425 crystallisation Methods 0.000 abstract 1
230000008025 crystallization Effects 0.000 abstract 1
238000000354 decomposition reaction Methods 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

BRPI0519270-6A 2004-12-27 2005-12-26 composiÇço farmacÊutica particulada estÁvel de solifenacina ou um sal BRPI0519270A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US63838804P	2004-12-27	2004-12-27
JP2005085968		2005-03-24
PCT/JP2005/023771 WO2006070735A1 (ja)	2004-12-27	2005-12-26	ソリフェナシンまたはその塩の安定な粒子状医薬組成物

Publications (1)

Publication Number	Publication Date
BRPI0519270A2 true BRPI0519270A2 (pt)	2009-01-06

Family

ID=40283425

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0519270-6A BRPI0519270A2 (pt)	2004-12-27	2005-12-26	composiÇço farmacÊutica particulada estÁvel de solifenacina ou um sal

Country Status (10)

Country	Link
JP (1)	JP4636445B2 (cs)
BG (1)	BG1677U1 (cs)
BR (1)	BRPI0519270A2 (cs)
CZ (1)	CZ23089U1 (cs)
ES (1)	ES2387571T3 (cs)
IL (1)	IL183877A0 (cs)
MX (1)	MX2007007911A (cs)
RU (1)	RU2397767C2 (cs)
SK (1)	SK6196Y1 (cs)
TW (1)	TW200635590A (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20140303254A1 (en) *	2013-04-08	2014-10-09	InnoPharma Licensing LLC	Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO2005012I1 (no) *	1994-12-28	2005-06-06	Debio Rech Pharma Sa	Triptorelin og farmasoytisk akseptable salter derav
CN100355419C (zh) *	2002-06-07	2007-12-19	安斯泰来制药有限公司	治疗膀胱过度活动的药物
JP4523265B2 (ja) *	2002-11-13	2010-08-11	旭化成ファーマ株式会社	排尿障害治療用口腔内崩壊製剤

2005
- 2005-12-26 BR BRPI0519270-6A patent/BRPI0519270A2/pt not_active IP Right Cessation
- 2005-12-26 CZ CZ201124173U patent/CZ23089U1/cs not_active IP Right Cessation
- 2005-12-26 RU RU2007128815/15A patent/RU2397767C2/ru not_active IP Right Cessation
- 2005-12-26 ES ES05820232T patent/ES2387571T3/es not_active Expired - Lifetime
- 2005-12-26 MX MX2007007911A patent/MX2007007911A/es active IP Right Grant
- 2005-12-26 JP JP2006550756A patent/JP4636445B2/ja not_active Expired - Fee Related
- 2005-12-26 BG BG1970U patent/BG1677U1/bg unknown
- 2005-12-26 SK SK5021-2011U patent/SK6196Y1/sk unknown
- 2005-12-27 TW TW094146775A patent/TW200635590A/zh unknown
2007
- 2007-06-12 IL IL183877A patent/IL183877A0/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
RU2397767C2 (ru)	2010-08-27
RU2007128815A (ru)	2009-02-10
BG1677U1 (bg)	2013-04-30
MX2007007911A (es)	2007-08-20
IL183877A0 (en)	2007-10-31
JPWO2006070735A1 (ja)	2008-06-12
ES2387571T3 (es)	2012-09-26
TW200635590A (en)	2006-10-16
SK50212011U1 (sk)	2012-01-04
JP4636445B2 (ja)	2011-02-23
CZ23089U1 (cs)	2011-12-19
SK6196Y1 (sk)	2012-08-06

Similar Documents

Publication	Publication Date	Title
BRPI0609719B8 (pt)	2021-05-25	derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2
NO20082124L (no)	2008-06-20	Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
SI2150530T1 (sl)	2012-02-29	Substituirani sulfonamidni derivati
MY142029A (en)	2010-08-16	Phenoxyacetic acid derivatives
UY30711A1 (es)	2008-07-03	Nuevos derivados de 1,4-benzotiepina-1, 1-cioxido, método para su preparacion, productos farmacéuticos que comprenden estos compuestos y su uso.-
CO6150162A2 (es)	2010-04-20	Pirrolopirimidinas para composiciones farmaceuticas
CA2918938C (en)	2021-05-18	Substituted aminopyrimidine compounds and methods of use
BR112014001880A2 (pt)	2017-02-21	derivados de carboxamida e ureia contendo pirazol heteroaromáticos substituídos como ligantes de receptor vaniloide
GEP201706780B (en)	2017-11-27	Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
MX2009011755A (es)	2010-02-12	Terapia de combinacion con un compuesto que actua como un inhibidor del receptor adp de plaquetas.
TW200801029A (en)	2008-01-01	Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
PT1951730E (pt)	2010-08-27	Derivados de pirimidina ligados a heteroalquilo
BR112015025766A2 (pt)	2017-10-17	derivado de nucleosídeo altamente ativo para o tratamento de hcv
BRPI0417043A (pt)	2007-02-06	composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
TW200505837A (en)	2005-02-16	Novel compounds
MX2009011089A (es)	2009-10-30	Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12.
SE0301009D0 (sv)	2003-04-07	Novel compounds
UY33246A (es)	2011-09-30	Tienopirimidinas que contienen cicloalquilo para composiciones farmacéuticas
MX2009003382A (es)	2009-04-08	Derivados de sulfonamidas sustituidos.
BR112015020772A2 (pt)	2017-07-18	compostos de pirimidina e piridina e seu uso
TW200630336A (en)	2006-09-01	Novel compounds
TW200621690A (en)	2006-07-01	Novel compounds
WO2007098964A3 (en)	2007-11-29	Pyrrazole derivatives as sigma receptors antagonists
WO2009027736A3 (en)	2009-04-23	2,4 diaminopyrimid'lnes for the treatment of myeloproliferative disorders and cancer
ATE425961T1 (de)	2009-04-15	Salze substituierter allophansaureester und deren verwendung in arzneimitteln

Legal Events

Date	Code	Title	Description
2017-10-31	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-02-20	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]